Sickle Cell Physicians Report Higher Burnout Rates Than Peers

Physicians dedicated to the care of patients with sickle cell disease experience burnout at a significantly higher rate than their colleagues who do not focus on this complex condition, according to a new cross-sectional survey published this month. The findings, emerging from research led at Yale School of Medicine, underscore the urgent need for systemic interventions to support clinicians working with a patient population facing both significant medical challenges and persistent social inequities.

The study, published in Blood Advances, represents the first dedicated examination of burnout rates specifically among physicians specializing in sickle cell disease. Researchers distributed a 49-item survey via social media and email to hematology/oncology-trained physicians, assessing burnout levels alongside measures of grit and resilience. While levels of grit – defined as perseverance and passion toward long-term goals – were comparable between groups, a notable disparity emerged in burnout rates. Approximately 60% of physicians primarily focused on sickle cell disease reported experiencing burnout, compared to 43% of those who did not specialize in the condition. Healio reports on the study findings.

Understanding Sickle Cell Disease and its Impact

Sickle cell disease is a group of inherited red blood cell disorders. Normally, red blood cells are round and flexible, allowing them to move easily through small blood vessels. In sickle cell disease, the red blood cells develop into rigid and shaped like sickles, leading to blockages in blood flow and causing pain, organ damage and other serious health problems. The Centers for Disease Control and Prevention (CDC) estimates that approximately 100,000 Americans are living with sickle cell disease, with over 90% of cases occurring among African Americans. A substantial proportion of remaining cases are found among Hispanic individuals.

Burnout in Oncology: A Growing Concern

Burnout, characterized by emotional exhaustion, depersonalization, and a reduced sense of personal accomplishment, is a pervasive issue within the medical profession. A recent ASCO survey revealed that 59% of medical oncologists in the United States reported burnout in 2023, a significant increase from 45% a decade earlier. However, until this recent study, burnout rates specifically within the subset of hematologists-oncologists dedicated to sickle cell disease remained largely unknown.

Factors Contributing to Burnout in Sickle Cell Care

Researchers suggest that several factors likely contribute to the elevated burnout rates observed among physicians treating sickle cell disease. A key challenge is the limited availability of disease-modifying therapies for sickle cell disease. While recent advances, such as gene therapies, offer hope, access remains uneven and these treatments are not yet widely available. This often leaves physicians managing primarily the symptoms of the disease, particularly acute pain crises, which can be frequent and debilitating.

systemic biases within the healthcare system can contribute to delayed or inadequate pain management for sickle cell patients, placing an additional burden on clinicians who must advocate for their patients’ needs. As Layla Van Doren, MD, MBA, assistant professor of medicine at Yale School of Medicine, explained to Healio, “Our study shows it is likely systemic health care system factors — not individual internal factors — that are leading to burnout in the small sickle cell-focused workforce.”

Survey Details and Findings

The study included responses from 159 physicians (median age 43, 71% women, 59% white). Approximately one-third (34.5%, n=55) self-identified as focusing on sickle cell disease. The survey assessed burnout using validated instruments, alongside measures of grit and resilience. Interestingly, the study found that physicians focused on sickle cell disease were more likely to have been in clinical practice for at least five years (81% vs. 63%, P = .016), but also more likely to report an annual income below $350,000 (64% vs. 40%, P = .005).

Researchers also noted that sickle cell-focused physicians were more likely to hold leadership or administrative roles (36% vs. 16%, P = .004) and dedicate a higher percentage of their time to teaching (10% vs. 5%, P = .031). Conversely, they were less likely to engage in recreational activities at least twice per week (45% vs. 59%, P = .006) and reported a lower sense of pride in their operate (47% vs. 65%, P = .031).

Looking Ahead: Further Investigation and Potential Solutions

The research team is currently conducting a follow-up survey specifically targeting clinicians who treat sickle cell disease. This next phase aims to delve deeper into the programmatic and institutional factors that contribute to burnout, examining aspects such as clinic resources, institutional support, and career development opportunities. Researchers will also assess levels of compassion fatigue, compassion satisfaction, and moral distress – the psychological discomfort experienced when knowing the ethically correct action but being unable to grab it due to systemic constraints.

Addressing burnout among sickle cell physicians will require a multi-faceted approach. Increased investment in research to develop and improve disease-modifying therapies is crucial. Addressing systemic biases in healthcare and ensuring equitable access to comprehensive care for sickle cell patients is equally important. Providing adequate resources and support for clinicians – including dedicated teams, administrative assistance, and opportunities for professional development – is essential to fostering a sustainable and fulfilling work environment.

As Van Doren emphasizes, recognizing and addressing burnout is not simply about individual well-being; it’s about ensuring the continued availability of skilled and compassionate care for a vulnerable patient population. The ongoing research promises to provide valuable insights into the specific challenges faced by these clinicians and inform the development of targeted interventions to mitigate burnout and improve the quality of care for individuals living with sickle cell disease. For more information on sickle cell disease, visit the National Heart, Lung, and Blood Institute.

Valentina Restrepo-Espinosa, MD, can be reached at [email protected].

Layla Van Doren, MD, MBA, can be reached at [email protected].